4.7 C
New York
Wednesday, December 6, 2023

The Street Is Finally Waking Up To Mersana Therapeutics Inc (NASDAQ: MRSN)

After Hours

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. After-hours trades for Mersana Therapeutics Inc (MRSN) shows that investor sentiment remained intact, with the stock’s consolidated last price rising by $0.0093, or 0.73%, to $1.2893. The Mersana Therapeutics Inc has recorded 14,492 volume in the after hours trading session. Earlier, Yahoo Finance discussed this stock as it revealed Mersana Therapeutics to Host Third Quarter 2023 Conference Call on November 7, 2023.

Stocks Info

Mersana Therapeutics Inc is listed on the NASDAQ as a member of the Healthcare sector and is a part of the Biotechnology industry. At the end of the last regular session, the stock closed at $1.28 and fluctuated between $1.2800 as its day high and $1.1601 as its day low. The current market capitalization of Mersana Therapeutics Inc is $154.25M. A total of 0.76 million shares were traded on the day, compared to an average of 2.39M shares.

Insider Activity

Additionally, investors take into account insider trades when predicting how a stock will perform. During the recent three months, MRSN has seen 4 BUY and 1 SELL insider trades, representing the acquisition of 49,777 and the disposition of 1,908 shares. Over the last 12 months, there were 33 BUYs and 10 SELLs from insiders. Insiders purchased 335,573 shares during that period but sold 47,113.

In the most recent transaction, Bala Mohan sold 1,912 shares of MRSN for 1.13 per share on Oct 26. After the transaction, the SVP, Chief Development Officer now owns 8,733 company shares. In a previous transaction on Aug 17, MISRA TUSHAR sold 1,908 shares at 1.18 per share. MRSN shares that SVP, Chief Manuf. Officer owns now total 11,507.

Among the insiders who sold shares, Carvajal Alejandra disposed of 3,944 shares on Apr 27 at a per-share price of $3.89. This resulted in the SVP, Chief Legal Officer holding 20,326 shares of MRSN after the transaction. In another insider transaction, Protopapas Anna sold 17,346 shares at $5.74 per share on Jan 17. Company shares held by the President & CEO now total 48,733.

Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. According to analysts who have offered 12-month price targets for MRSN in the last 3 months, the mean price target is $2.00 with high estimates of $4.00 and low estimates of $1.00. In terms of 52-week highs and lows, MRSN has a high of $9.62 and a low of $0.80.

As of this writing, MRSN has an earnings estimate of -$0.36 per share for the current quarter. EPS was calculated based on a consensus of 9 estimates, with a high estimate of -$0.24 per share and a lower estimate of -$0.6. The company reported an EPS of -$0.52 in the last quarter, which was -18.20% lower than expectations of -$0.44.

Balance Sheet Annually/Quarterly

A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information. MRSN’s latest balance sheet shows that the firm has $177.95M in Cash & Short Term Investments as of fiscal 2021. There were $38.18M in debt and $47.52M in liabilities at the time. Its Book Value Per Share was $0.75, while its Total Shareholder’s Equity was $121.74M.

Analysts Opinion

It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for MRSN is Buy with a score of 3.22.

Related Articles


Please enter your comment!
Please enter your name here

Latest Articles